NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Read More
Corporate News

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

Read More
Corporate News

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland

Read More
Corporate News

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Read More
Corporate News

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

Read More
Corporate News

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

Read More